*	OR T1 T2
R1	Has_temporal Arg1:T1 Arg2:T3	
R2	Has_temporal Arg1:T2 Arg2:T3	
R3	AND Arg1:T4 Arg2:T6	
R4	Has_value Arg1:T4 Arg2:T5	
*	OR T7 T8
R5	Has_value Arg1:T8 Arg2:T9	
R6	Has_value Arg1:T7 Arg2:T9	
R7	Has_value Arg1:T10 Arg2:T11	
R8	Has_value Arg1:T12 Arg2:T13	
R9	Has_qualifier Arg1:T15 Arg2:T16	
R10	Has_value Arg1:T17 Arg2:T18	
*	OR T14 T15 T17
*	OR T20 T21
R11	Has_value Arg1:T19 Arg2:T20	
*	OR T23 T24 T25
R12	Has_temporal Arg1:T23 Arg2:T26	
R13	Has_temporal Arg1:T25 Arg2:T26	
R14	Has_temporal Arg1:T24 Arg2:T26	
R15	Has_temporal Arg1:T30 Arg2:T31	
R16	Has_negation Arg1:T34 Arg2:T35	
R17	AND Arg1:T33 Arg2:T34	
*	OR T33 T36 T37
R18	Has_value Arg1:T38 Arg2:T39	
*	OR T40 T41
*	OR T27 T28
R19	Has_multiplier Arg1:T47 Arg2:T46	
R20	multi Arg1:T44 Arg2:T47	
R21	Has_index Arg1:T29 Arg2:T44	
R22	Has_temporal Arg1:T27 Arg2:T29	
T1	Drug 12 24	antiplatelet
T2	Drug 28 41	anticoagulant
T3	Temporal 0 11	Concomitant
T4	Measurement 47 78	Calculated creatinine clearance
T5	Value 79 90	< 30 mL/min
T6	Measurement 94 117	Cockcroft-Gault formula
T7	Measurement 119 149	Alanine aminotransferase (ALT)
T8	Measurement 153 185	aspartate aminotransferase (AST)
T9	Value 186 223	> 3 times upper limit of normal (ULN)
T10	Measurement 225 240	Total bilirubin
T11	Value 241 250	> 2 x ULN
T12	Measurement 252 268	Thrombocytopenia
T13	Value 269 294	< 50 x 10 gigalitres (Gl)
T14	Condition 296 314	High bleeding risk
T15	Condition 332 358	prolonged prothrombin time
T16	Qualifier 318 331	spontaneously
T17	Measurement 362 399	activated partial thromboplastin time
T18	Value 400 411	> 1.5 x ULN
T19	Condition 413 424	Body weight
T20	Value 425 428;437 439	<50 kg
T21	Value 432 439	>120 kg
T23	Drug 460 466	CYP3A4
T24	Drug 470 493	p-glycoprotein inducers
T25	Drug 470 484;497 507	p-glycoprotein inhibitors
T26	Temporal 441 452	Concomitant
T27	Drug 516 529	Ginkgo biloba
T30	Drug 597 610	Dexamethasone
T31	Temporal 615 635	within last 3 months
T32	Person 637 642	Women
T33	Condition 646 668	Childbearing potential
T34	Procedure 684 706	contraceptive measures
T35	Negation 669 676	without
T36	Condition 708 717	pregnancy
T37	Observation 721 735	breast feeding
T38	Observation 737 752	Life expectancy
T39	Value 753 771	less than 3 months
T40	Condition 773 793	Inability to swallow
T41	Condition 797 822	issues with malabsorption
T42	Undefined_semantics 797 822	issues with malabsorption
T43	Subjective_judgement 824 1001	Any other medical, social, logistical, geographical or psychological factors, which in the opinion of the investigator, would prohibit follow-up, compliance and study completion
T45	Context_Error 824 1001	Any other medical, social, logistical, geographical or psychological factors, which in the opinion of the investigator, would prohibit follow-up, compliance and study completion
T28	Drug 533 548	St. John's Wort
T29	Temporal 549 595	within 14 days before first dose of study drug
T44	Reference_point 571 595	first dose of study drug
T46	Multiplier 571 581	first dose
T47	Drug 585 595	study drug
